Isolation and in-vitro and in-vivo characterisation of a mutant of pseudomonas aeruginosa PAO1 that exhibited a reduced postantibiotic effect in response to imipenem

Journal of Antimicrobial Chemotherapy

Volumn 34, Issue 4, 1994, Pages 485-505

  Majcherczyk, P A ^a,b   Kunz, S ^b   Hattenberger, M ^b   Vaxelaire, J ^b   Zak, O ^b   O'reilly, T ^b  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b CIBA GEIGY LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; IMIPENEM; N ACETYLGLUCOSAMINE; OUTER MEMBRANE PROTEIN; PENEM DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CULTURE; BACTERIUM ISOLATION; BACTERIUM MUTANT; CELL VOLUME; CHEMOSTAT; CONTROLLED STUDY; CULTURE MEDIUM; DRUG REEXPOSURE; ESCHERICHIA COLI; FEMALE; GRAM NEGATIVE BACTERIUM; GROWTH INHIBITION; IMPEDANCE; INFECTION; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; POSTANTIBIOTIC EFFECT; PSEUDOMONAS AERUGINOSA; THIGH;

ACETYLGLUCOSAMINE; ANIMAL; BACTERIAL OUTER MEMBRANE PROTEINS; ELECTRIC CONDUCTIVITY; ESCHERICHIA COLI; FEMALE; IMIPENEM; LEUKOPENIA; MICE; MICE, INBRED STRAINS; MICROBIAL SENSITIVITY TESTS; MUTATION; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 0028104552     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/34.4.485     Document Type: Article

References (25)

1. Bailey, N. T. J. (1992). Statistical Methods in Biology, 2nd edn, pp. 90-8. Cambridge University Press, Cambridge.
2. Bundtzen, R. W., Gerber, A. U., Cohn, D. L. and Craig, W. A. (1981). Postantibiotic suppression of bacterial growth. Reviews of Infectious Diseases 3, 28-37.
3. Bustamante, C. I., Drusano, G. L., Tatem, B. A. and Standiford, H. C. (1984). Postantibiotic effect of imipenem on Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 26, 678-82.
4. Carbon, C. (1990). Significance of tissue levels for prediction of antibiotic efficacy and determination of dosage. European Journal of Clinical Microbiology and Infectious Diseases 9, 510-6.
5. Chin, N. X. and Neu, H. C. (1989). In-vitro activity of FCE 22101 and synergy studies with other antimicrobial agents. Journal of Antimicrobial Chemotherapy 23, Suppl. C, 95-101.
6. Craig, W. A., Redington, J. and Ebert, S. C. (1991). Pharmacodynamics of amikacin in vitro and in mouse thigh and lung infections. Journal of Antimicrobial Chemotherapy 27, Suppl. C, 29-40.
7. Drusano, G. L. (1988). Role of pharmacokinetics in the outcome of infections. Antimicrobial Agents and Chemotherapy 32, 289-97.
8. Finch, R. G., Craddock, C., Kelly, J. and Deaney, N. B. (1986). Pharamcokinetic studies of imipenem/cilastatin in elderly patients. Journal of Antimicrobial Chemotherapy 18, Suppl. E, 103-7.
9. Flückiger, U., Segessenmann, C. and Gerber, A. U. (1991). Integration of pharmacokinetics and pharmacodynamics of imipenem in a human-adapted mouse model. Antimicrobial Agents and Chemotherapy 35, 1905-10.
10. Guan, L. and Burnham, J. C. (1992). Postantibiotic effect of CI-960, enoxacin and ciprofloxacin on Escherichia coli, effect on morphology and haemolysin activity. Journal of Antimicrobial Chemotherapy 29, 529-38.
11. Gudmundsson, S., Vogelman, B. and Craig, W. A. (1986). The in-vivo post antibiotic effect of imipenem and other new antimicrobials. Journal of Antimicrobial Chemotherapy 18, Suppl. E, 67-73.
12. Hessen, M. T., Pitsakis, P. G. and Levison, M. E. (1988). Absence of a postantibiotic effect in experimental pseudomonas endocarditis treated with imipenem, with or without gentamicin. Journal of Infectious Diseases 158, 542-8.
13. Jabés, D., Rossi, R. and Della Bruna, C. (1992). Postantibiotic effect of the oral penem FCE 25199 in vitro and in vivo by a new cage model in mice. In Program and Abstracts of the Thirty-Second Interscience Conference on Antimicrobial Agents and Chemotherapy, Anaheim. Abstract 385, p. 175. American Society for Microbiology, Washington, DC.
14. Karlowsky, J. A., Zhanel, G. G., Davidson, R. J., Zieroth, S. R. and Hoban, D. J. (1993). In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton broth. Antimicrobial Agents and Chemotherapy 37, 1154-7.
15. MacGregor, R. R., Gibson, G. A. and Bland, J. A. (1986). Imipenem pharmacokinetics and body fluid concentrations in patients receiving high-dose treatment for serious infections. Antimicrobial Agents and Chemotherapy 29, 188-92.
16. Manek, N., Andrews, J. M. and Wise, R. (1986). The postantibiotic effect of imipenem. Journal of Antimicrobial Chemotherapy 18, 641.
17. McDonald, P. J., Craig, W. A. and Kunin, C. M. (1977). Persistent effect of antibiotics on Staphylococcus aureus after exposure for limited periods of time. Journal of Infectious Diseases 135, 217-23.
18. McGrath, B. J., Marchbanks, C. R., Gilbert, D. and Dudley, M. N. (1993). In vitro postantibiotic effect following repeated exposure to imipenem, temafloxacin and tobramycin. Antimicrobial Agents and Chemotherapy 37, 1723-5.
19. Nadler, H. L., Pitkin, D. H. and Sheikh, W. (1989). The postantibiotic effect of meropenem and imipenem on selected bacteria. Journal of Antimicrobial Chemotherapy 24, Suppl. A., 225-31.
20. Niven, D. F., Donga, J. and Archibald, F. S. (1989). Response of Haemophilus pleuropneumoniae to iron restriction, changes in the outer membrane protein profile and the removal of iron from porcine transferrin. Molecular Microbiology 3, 1083-89.
21. Renneberg, J. and Wälder M. (1989). Postantibiotic effects of imipenem, norfloxacin, and amikacin in vitro and in vivo. Antimicrobial Agents and Chemotherapy 33, 1714-20.
22. Roberts R. B., Cowie, D. B., Abelson, P. H., Bolton, E. T. and Britten, R. J. (1957). Studies of biosynthesis in Escherichia coli, 2nd printing. Carnegie Institution of Washington Publication 607, p. 5.
23. Trias, J. and Nikaido, H. (1990). Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrobial Agents and Chemotherapy 34, 52-7.
24. Wilson, D. A. and Rolinson, G. N. (1979). The recovery period following exposure of bacteria to penicillins. Chemotherapy 25, 14-22.
25. Wu, P. J. and Livermore, D. M. (1990). Response of chemostat cultures of Pseudomonas aeruginosa to carbapenems and other ß -lactams. Journal of Antimicrobial Chemotherapy 25, 891-902.